Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves’ Hyperthyroid Patients: A Randomized Prospective Controlled Study

Table 2

Cumulative rates of recurrent hyperthyroidism in 173 patients randomly assigned to discontinue and continue low-dose methimazole therapy.

Time after randomization (months)	Cumulative rates of recurrent hyperthyroidism after randomization (%)
	DISCONT-MMI (90 cases)	CONT-MMI (83 cases)
6	11.2	1.2
12	18.4	6.8
18	27.2	11.0
24	35.0	11.0
36	41.2	11.0

DISCONT-MMI and CONT-MMI denoted patients who were randomly assigned to discontinue and continue low-dose methimazole therapy, respectively.